Spots Global Cancer Trial Database for thromboprophylaxis
Every month we try and update this database with for thromboprophylaxis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer | NCT05178628 | Pancreatic Canc... Thromboembolism | Innohep Chemotherapy: G... | 18 Years - | Institute of Molecular Medicine and Biomedical Research | |
| Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) | NCT03532139 | Ovarian Cancer | Enoxaparin Enoxaparin + Ro... Thromboprophyla... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports | NCT04309240 | Rivaroxaban Thromboprophyla... Cancer | Rivaroxaban | 18 Years - 75 Years | LiuZhou People's Hospital | |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | NCT00966277 | Pancreatic Canc... Venous Thromboe... | Dalteparin | 18 Years - | M.D. Anderson Cancer Center | |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin | NCT04999176 | Cancer Rivaroxaban Venous Thromboe... Thromboprophyla... | Rivaroxaban Enoxaparin | 18 Years - 89 Years | Science Valley Research Institute | |
| Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) | NCT03532139 | Ovarian Cancer | Enoxaparin Enoxaparin + Ro... Thromboprophyla... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines | NCT03506815 | Upper Extremity... Central Venous ... Cancer | Rivaroxaban 10 ... | 18 Years - | Ottawa Hospital Research Institute | |
| Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) | NCT03532139 | Ovarian Cancer | Enoxaparin Enoxaparin + Ro... Thromboprophyla... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports | NCT04309240 | Rivaroxaban Thromboprophyla... Cancer | Rivaroxaban | 18 Years - 75 Years | LiuZhou People's Hospital | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery | NCT01444612 | Thrombosis, Ven... | dalteparin enoxaparin fondaparinux unfractionated ... | 18 Years - | GlaxoSmithKline | |
| Prophylactic Anticoagulation for Catheter-related Thrombosis | NCT04256525 | Venous Thrombos... Prophylactic An... Patients With T... | Rivaroxaban 10m... Aspirin 100mg low molecule he... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment | NCT04744688 | Peritoneal Meta... Peritoneal Carc... Colorectal Neop... Intestinal Neop... Cytoreductive S... Venous Thromboe... Bleeding Laparoscopic Su... Coagulation Surgical Proced... Postoperative C... Laparoscopy Minimally Invas... Surgical Oncolo... | 18 Years - | University of Aarhus | ||
| Biomarkers in Multiple Myeloma | NCT05259553 | Hematological P... Newly Diagnosed... Chemotherapy | Blood samples | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer | NCT05178628 | Pancreatic Canc... Thromboembolism | Innohep Chemotherapy: G... | 18 Years - | Institute of Molecular Medicine and Biomedical Research | |
| Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery | NCT06302179 | Colorectal Canc... Venous Thromboe... | 18 Years - | Pirogov Russian National Research Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
